About this trial
This prospective observational cross-sectional study aims to evaluate the relationships among fetal health locus of control (FHLC) perceptions, maternal anxiety levels, and fetal cardiotocography parameters in high-risk pregnant women. Pregnant women at 32 weeks of gestation or later who undergo routine non-stress testing (NST) at the Perinatology Outpatient Clinic will be invited to participate. On the same day as the routine NST, participants will complete the Fetal Health Locus of Control Scale and the Beck Anxiety Inventory. Associations between FHLC dimensions, maternal anxiety levels, and NST parameters, including baseline fetal heart rate, number of accelerations, reactivity, and presence of decelerations, will be evaluated.
Eligibility criteria
Qualifiers
Singleton pregnancy at 32 weeks of gestation or later
Being followed for a high-risk pregnancy
No known diagnosed psychiatric disorder and no current psychiatric medication use
Absence of a fetal condition considered likely to affect the NST tracing
Disqualifiers
Gestational age below 32 weeks and/or multiple pregnancy
Presence of a fetal condition considered likely to affect the NST tracing
Acute maternal infection or an obstetric emergency
Known diagnosed psychiatric disorder and/or current psychiatric medication use
Trial design
Treatments tested in this trial
- Not listed